Go to the page content
BMI

Provjerite svoj ITM pomoću ITM kalkulatora

Indeks tjelesne mase (ITM) je alat koji se često koristi kao zamjenska mjera tjelesne masnoće i može identificirati debljinu i povezane zdravstvene rizike. Može se izračunati pomoću ITM kalkulatora na temelju visine i težine, a rezultati se mogu kategorizirati u različite skupine, od pothranjenosti do debljine III. stupnja.

3 min. čitanja

Izračunajte svoj ITM i zdravstvene rizike

Metrički sustav Imperijalni sustav
Metrički sustav / Imperijalni sustav

ITM kalkulator: Provjerite svoj ITM sada

Možete koristiti ITM kalkulator ovdje kako biste podijelili svoju težinu u kilogramima s vašom visinom u metrima i usporedili svoj rezultat sa skupinama ITM-a. Unesite svoju visinu i težinu te provjerite svoje rezultate u tablici ispod. Kliknite na skupinu ITM-a kako biste saznali više.

KlasifikacijaITM
PothranjenostIspod 18,5
Normalna težina18,5-24,9
Preuhranjenost25,0-29,9
Debljina30 i više
Stupanj I30,0-34,9
Stupanj II35,0-39,9
Stupanj III40 i više
  • Klasifikacija prema Svjetskoj zdravstvenoj organizaciji (WHO). Ovaj ITM kalkulator namijenjen je odraslima starim 20 godina ili više. Razgovarajte sa svojim liječnikom o svom ITM-u ako imate manje od 20 godina. Klasifikacije ITM-a su zasnovane na klasifikaciji ITM-a Svjetske zdravstvene organizacije (WHO).

 

Zašto je važno znati svoj ITM?

ITM je dobar način za provjeru rizika od bolesti povezanih s tjelesnom masnoćom. Život s prekomjernom težinom ili debljinom povezan je s povećanim rizikom od smrtnosti i drugih bolesti ili stanja. Općenito, što je vaš ITM viši, veći je rizik od razvoja drugih kroničnih bolesti povezanih s debljinom, kao što su:

  • Šećerna bolest tipa II
  • Visoka razina šećera u krvi
  • Visoka razina kolesterola
  • Visoki krvni tlak
  • Neplodnost
  • Depresija i anksioznost
  • Koronarna bolest srca poput srčanog udara
  • Dislipidemija
  • Metabolička disfunkcija povezana s steatohepatitisom (MASH) / Metabolička disfunkcija povezana s steatotskom bolešću jetre (MASLD)
  • Gastroezofagealna refluksna bolest (GERD)
  • Metabolički sindrom (MetS)
  • Urinarna inkontinencija
  • Opstruktivna apneja u snu i problemi s disanjem
  • Kronična bolest bubrega
  • Različite vrste raka: uključujući, ali ne ograničavajući se na - dojke, debelog crijeva, endometrija, jednjaka, bubrega, jajnika i gušterače
  • Osteoartritis koljena
  • Bolest žučnih kamenaca
  • Tromboza
  • Giht
  • Moždani udar

Razgovarajte sa svojim liječnikom za više informacija o bilo kojoj od ovih bolesti i kako su povezane s vašim ITM-om. Također, možete saznati više o zdravstvenim koristima gubitka težine ovdje.

Koja su ograničenja ITM-a?

ITM je jednostavno i objektivno mjerilo, ali može biti zavaravajuće u određenim slučajevima i za neke skupine ljudi. Istraživanja su pokazala da je ITM manje točan u predviđanju rizika od bolesti kod starijih osoba, sportaša, onih koji su visoki ili niski i onih s više mišićne mase. Na primjer, elitni sportaši ili bodybuilderi imaju više mišića i teže više, što čini njihov ITM višim.

ITM također ne uzima u obzir:

  • Nasljedne čimbenike rizika povezane s bolestima povezanima s debljinom, poput metaboličkog sindroma
  • Ekološke i životne čimbenike osim debljine koji mogu pridonijeti vašem riziku od razvoja kroničnih bolesti
  • Kako je tjelesna masnoća raspoređena kod pojedinaca

Važno je zapamtiti da život s debljinom ne znači nužno da ste nezdravi, kao što biti u 'normalnoj' težini ne znači da ste zdravi. Vaš ITM vas ne definira, ali znanje i razumijevanje vašeg ITM-a može biti moćan alat za preuzimanje kontrole nad vlastitim zdravljem.

Bez obzira na vaš ITM, stručnjaci preporučuju zdravu prehranu i način života. Razgovarajte sa svojim liječnikom o svojoj težini i zdravlju te procijenite koji koraci mogu biti potrebni.

Kako ITM i omjer struka i visine mogu pomoći u upravljanju zdravljem srca

Ljudi koji žive s prekomjernom težinom ili debljinom imaju veći rizik od razvoja kardiovaskularnih bolesti, također poznatih kao bolesti srca.

Iako se i ITM i omjer struka i visine (WtHR) mogu koristiti za procjenu rizika osobe od razvoja kardiovaskularnih bolesti, WtHR se smatra boljim prediktorom kardiovaskularnih faktora rizika, poput visokog krvnog tlaka i visokog kolesterola.

ITM se koristi za označavanje kategorije težine osobe, na temelju njezine visine i težine. S druge strane, WtHR se koristi za mjerenje raspodjele tjelesne masnoće osobe, na temelju njezine visine i opsega struka. Mjerenje WtHR je važno jer je višak masnoće pohranjen oko trbuha posebno povezan s povećanim rizikom od razvoja bolesti srca.

Poznavanje vašeg ITM-a i WtHR-a može vam pomoći da poboljšate zdravlje srca jer ćete bolje razumjeti trebaju li se poduzeti mjere za upravljanje vašom težinom.

Kliknite ovdje kako biste izračunali svoj omjer struka i visine i provjerili što to znači za vas.

Reference
  1. Lopez-Jimenez F, Almahmeed W, Bays H, et al. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. Eur J Prev Cardiol. 2022 Dec 7;29(17):2218-2237. doi: 10.1093/eurjpc/zwac187. PMID: 36007112.
  2. Zhang, S., Fu, X., Du, Z. et al. Is waist-to-height ratio the best predictive indicator of cardiovascular disease incidence in hypertensive adults? A cohort study. BMC Cardiovasc Disord 22, 214 (2022). https://doi.org/10.1186/s12872-022-02646-1
  3. Rueda-Clausen, C F et al, “Assessment of People Living with Obesity,” Can. Adult Obes. Clin. Pract. Guidel., pp. 1–17, 2020, [Online]. Available: http://obesitycanada.ca/wp-content/uploads/2020/09/6-Obesity-Assessment-v5-with-links.pdf.
  4. Yumuk, V et al, “European Guidelines for Obesity Management in Adults” Obes Facts. 2015 Dec; 8(6): 402–424. Published online 2015 Dec 5. doi: 10.1159/000442721.
  5. Garvey, W T et al, “American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.” Endocrine Practice 2016;22:1–203. DOI:https://doi.org/10.4158/EP161365.GL
  6. Guh, D P et al, “The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis,” BMC Public Health, vol. 9, no. 1, p. 88, 2009, doi: 10.1186/1471-2458-9-88.
  7. Prospective Studies Collaboration, “Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies,” Lancet, vol. 373, no. 9669, pp. 1083–1096, Mar. 2009, doi: 10.1016/S0140-6736(09)60318-4.
  8. “Obesity Screening – Medline Plus, U.S. National Library of Medicine” Available: https://medlineplus.gov/lab-tests/obesity-screening/.
  9. “Assessing Your Weight and Health Risk – National Heart, Lung, and Blood Association – U.S. Department of Health & Human Services” Available: https://www.nhlbi.nih.gov/health/educational/lose_wt/risk.htm.
  10. Hussain, A et al, “Type 2 Diabetes and obesity: A review” Journal of Diabetology, June 2010; 2:1.
  11. Katzmarzyk, P T et al, “Body mass index and risk of cardiovascular disease, cancer and all-cause mortality” Can. J. Public Health, vol. 103, no. 2, pp. 147–151, 2012, doi: 10.1007/BF03404221.
  12. Kurth, T et al, “Prospective Study of Body Mass Index and Risk of Stroke in Apparently Healthy Women,” Circulation, vol. 111, no. 15, pp. 1992–1998, Apr. 2005, doi: 10.1161/01.CIR.0000161822.83163.B6.
  13. Landi, F et al, “Body Mass Index is Strongly Associated with Hypertension: Results from the Longevity Check-Up 7+ Study” Nutrients. 2018 Dec; 10(12): 1976. Published online 2018 Dec 13. doi: 10.3390/nu10121976.
  14. Dağ, Z Ö et al, “Impact of obesity on infertility in women,” J. Turkish Ger. Gynecol. Assoc., vol. 16, no. 2, pp. 111–117, Jun. 2015, doi: 10.5152/jtgga.2015.15232.
  15. Moussa, O M et al, “Effect of body mass index on depression in a UK cohort of 363037 obese patients: A longitudinal analysis of transition,” Clin. Obes., vol. 9, no. 3, p. e12305, Jun. 2019, doi: https://doi.org/10.1111/cob.12305.
  16. Zhao, G et al, “Depression and anxiety among US adults: associations with body mass index,” Int. J. Obes., vol. 33, no. 2, pp. 257–266, 2009, doi: 10.1038/ijo.2008.268.
  17. Lamon-Fava, S et al, “Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women,” Arterioscler. Thromb. Vasc. Biol., vol. 16, no. 12, pp. 1509–1515, Dec. 1996, doi: 10.1161/01.ATV.16.12.1509.
  18. Van Hemelrijck, M et al, “Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria” Published: June 13, 2018https://doi.org/10.1371/journal.pone.0197830.
  19. Loomis, A K et al, “Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies,” J. Clin. Endocrinol. Metab., vol. 101, no. 3, pp. 945–952, Mar. 2016, doi: 10.1210/jc.2015-3444.
  20. Zafar, S et al, “Correlation of gastroesophageal reflux disease symptoms with body mass index,” Saudi J. Gastroenterol., vol. 14, no. 2, pp. 53–57, Apr. 2008, doi: 10.4103/1319-3767.39618.
  21. Han, T S et al, “A clinical perspective of obesity, metabolic syndrome and cardiovascular disease,” JRSM Cardiovasc. Dis., vol. 5, pp. 2048004016633371–2048004016633371, Feb. 2016, doi: 10.1177/2048004016633371.
  22. Subak, L L et al, “Obesity and Urinary Incontinence: Epidemiology and Clinical Research Update” J Urol. 2009 Dec; 182(6 Suppl): S2–S7 doi: 10.1016/j.juro.2009.08.071.
  23. Romero-Corral, A et al, “Interactions Between Obesity and Obstructive Sleep Apnea - Implications for Treatment” Chest. 2010 Mar; 137(3): 711–719. doi: 10.1378/chest.09-0360.
  24. Herrington, W G et al, “Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England,” PLoS One, vol. 12, no. 3, p. e0173515, Mar. 2017, [Online]. Available: https://doi.org/10.1371/journal.pone.0173515.
  25. Bhaskaran, K et al, “Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults,” Lancet, vol. 384, no. 9945, pp. 755–765, Aug. 2014, doi: 10.1016/S0140-6736(14)60892-8.
  26. Zheng, H et al, “Body mass index and risk of knee osteoarthritis: Systematic review and meta-analysis of prospective studies,” BMJ Open, vol. 5, no. 12, 2015, doi: 10.1136/bmjopen-2014-007568.
  27. Su, Y P et al, “Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years” BMC Gastroenterol 19, 117 (2019). https://doi.org/10.1186/s12876-019-1032-y.
  28. Yang, G et al, “The effects of obesity on venous thromboembolism: A review” Open J Prev Med. 2012 Nov; 2(4): 499–509. doi: 10.4236/ojpm.2012.24069.
  29. Bai, L et al, “Incident gout and weight change patterns: a retrospective cohort study of US adults” Arthritis Res Ther. 2021; 23: 69. Published online 2021 Mar 2. doi: 10.1186/s13075-021-02461-7.
  30. Klatsky, A L et al, “Body Mass Index and Mortality in a Very Large Cohort: Is It Really Healthier to Be Overweight?,” Perm. J., vol. 21, pp. 16–142, 2017, doi: 10.7812/TPP/16-142.
  31. Heymsfield, S B et al, “Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review,” Obes. Rev., vol. 17, no. 3, pp. 262–275, Mar. 2016, doi: 10.1111/obr.12358.
  32. “Ethnic Differences in BMI and Disease Risk | Obesity Prevention Source | Harvard T.H. Chan School of Public Health.” [Online]. Available: https://www.hsph.harvard.edu/obesity-prevention-source/ethnic-differences-in-bmi-and-disease-risk/.
  33. Cossrow, N et al, “Race/Ethnic Issues in Obesity and Obesity-Related Comorbidities,” J. Clin. Endocrinol. Metab., vol. 89, no. 6, pp. 2590–2594, Jun. 2004, doi: 10.1210/jc.2004-0339.
  34. “Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies – Public Health – WHO international” Available: https://www.who.int/nutrition/publications/bmi_asia_strategies.pdf.
  35. Deurenberg-Yap, M et al, “The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore.” Int J Obes Relat Metab Disord. 2000 Aug;24(8):1011-7. doi: 10.1038/sj.ijo.0801353. PMID: 10951540.
  36. Valentino, G et al, “Body fat and its relationship with clustering of cardiovascular risk factors” Nutr Hosp. 2015;31(5):2253-2260 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318.
  37. Lear, S A et al, “Ethnic Variation in Fat and Lean Body Mass and the Association with INS Resistance” The Journal of Clinical Endocrinology & Metabolism, Volume 94, Issue 12, 1 December 2009, Pages 4696–4702, https://doi.org/10.1210/jc.2009-1030.
  38. Tillin, T et al, “The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study,” J. Am. Coll. Cardiol., vol. 61, no. 17, pp. 1777–1786, Apr. 2013, doi: 10.1016/j.jacc.2012.12.046.
  39. Tanne, D et al, “Body Fat Distribution and Long-Term Risk of Stroke Mortality” Stroke. Originally published 31 Mar 2005 https://doi.org/10.1161/01.STR.0000162584.39366.1c.
  40. Chen, Y et al, “Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium,” BMJ Br. Med. J., vol. 347, p. f5446, Oct. 2013, doi: 10.1136/bmj.f5446.
  41. Wen, C P et al, “Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians” Public Health Nutrition, 12(4), 497-506. doi:10.1017/S1368980008002802.
  42. J. S. for the S. of O. The Examination Committee of Criteria for `Obesity Disease’ in Japan, “New Criteria for `Obesity Disease’ in Japan,” Circ. J., vol. 66, no. 11, pp. 987–992, 2002, doi: 10.1253/circj.66.987.
  43. Zheng, W et al, “Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians,” N. Engl. J. Med., vol. 364, no. 8, pp. 719–729, Feb. 2011, doi: 10.1056/NEJMoa1010679.
  44. Aekplakorn, W et al, “Obesity indices and cardiovascular risk factors in Thai adults.” Int J Obes 30, 1782–1790 (2006). https://doi.org/10.1038/sj.ijo.0803346.
  45. Choi, S E et al, “Do Risk Factors Explain the Increased Prevalence of Type 2 Diabetes Among California Asian Adults?” J Immigr Minor Health. 2011; 13(5): 803–808. Published online 2010 Oct 9. doi: 10.1007/s10903-010-9397-6.
  46. Swinburn, B et al, “Body size and composition in Polynesians” Int J Obes 23, 1178–1183 (1999). https://doi.org/10.1038/sj.ijo.0801053.
  47. Young, D R et al, “Associations of overweight/obesity and socioeconomic status with hypertension prevalence across racial and ethnic groups,” J. Clin. Hypertens., vol. 20, no. 3, pp. 532–540, Mar. 2018, doi: https://doi.org/10.1111/jch.13217.
  48. Maskarinec, G et al, “Diabetes Prevalence and Body Mass Index Differ by Ethnicity: The Multiethnic Cohort” Ethn Dis. 2009; 19(1): 49–55. PMCID: PMC2702477.
  49. Aleman-Mateo, H et al, “Elderly Mexicans have less muscle and greater total and truncel fat compared to African-Americans and Caucasians with the same BMI” J Nutr Health Aging. 2009 Dec; 13(10): 919. doi: 10.1007/s12603-009-0252-1.
  50. Cossrow, N et al, “Race/Ethnic Issues in Obesity and Obesity-Related Comorbidities” The Journal of Clinical Endocrinology & Metabolism, Volume 89, Issue 6, 1 June 2004, Pages 2590–2594, https://doi.org/10.1210/jc.2004-0339.
  51. Berber, A et al, “Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population,” Int. J. Obes., vol. 25, no. 12, pp. 1794–1799, 2001, doi: 10.1038/sj.ijo.0801827.
  52. Chirinos, D A et al, “Defining Abdominal Obesity as a Risk Factor for Coronary Heart Disease in the U.S.: Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)” Diabetes Care Aug 2020, 43 (8) 1774-1780; DOI: 10.2337/dc19-1855.
  53. Elo, I T et al, “The Contribution of Weight Status to Black-White Differences in Mortality” Biodemography Soc Biol. 2017; 63(3): 206–220. doi: 10.1080/19485565.2017.1300519.
  54. “9 The evidence | BMI: preventing ill health and premature death in black, Asian and other minority ethnic groups | Guidance | NICE.” [Online]. Available: https://www.nice.org.uk/guidance/ph46/chapter/9-The-evidence.
  55. Alammar, M et al, “Diagnostic Accuracy of Body Mass Index (BMI) When Diagnosing Obesity in a Saudi Adult Population in a Primary Care Setting, Cross Sectional, Retrospective Study” Diabetes Metab Syndr Obes. 2020; 13: 2515–2520. Published online 2020 Jul 14. doi: 10.2147/DMSO.S263063.
  56. Bennet, L et al, “BMI and waist circumference cut-offs for corresponding levels of INS sensitivity in a Middle Eastern immigrant versus a native Swedish population – the MEDIM population based study” BMC Public Health. 2016; 16: 1242. Published online 2016 Dec 9. doi: 10.1186/s12889-016-3892-1.
  57. Al-Raddadi, R et al, “The prevalence of obesity and overweight, associated demographic and lifestyle factors, and health status in the adult population of Jeddah, Saudi Arabia,” Ther. Adv. Chronic Dis., vol. 10, p. 2040622319878997, Jan. 2019, doi: 10.1177/2040622319878997.
  58. Abell, J E et al, “Differences in Cardiovascular Disease Mortality Associated With Body Mass Between Black and White Persons,” Am. J. Public Health, vol. 98, no. 1, pp. 63–66, Jan. 2008, doi: 10.2105/AJPH.2006.093781.
  59. Batsis, J A et al, “Diagnostic Accuracy of Body Mass Index to Identify Obesity in Older Adults: NHANES 1999–2004” Int J Obes (Lond). 2016 May; 40(5): 761–767. Published online 2015 Dec 1. doi: 10.1038/ijo.2015.243
  60. Michigan State University. "BMI Not Accurate Indicator Of Body Fat, New Research Suggests." ScienceDaily. ScienceDaily, 7 March 2007. Available: www.sciencedaily.com/releases/2007/03/070305202535.htm.
  61. Sperrin, M et al, “Body mass index relates weight to height differently in women and older adults: serial cross-sectional surveys in England (1992-2011)” J. Public Health (Oxf)., vol. 38, no. 3, pp. 607–613, Sep. 2016, doi: 10.1093/pubmed/fdv067.
  62. Weir CB, et al, “BMI Classification Percentile And Cut Off Points.” In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
  63. “What Is My Ideal Body Fat Percentage? - Healthline” [Online] Available: https://www.healthline.com/health/exercise-fitness/ideal-body-fat-percentage.
  64. Nuttall, F Q. “Body Mass Index: Obesity, BMI, and Health: A Critical Review” Nutr Today. 2015 May; 50(3): 117–128. Published online 2015 Apr 7. doi: 10.1097/NT.0000000000000092.
  65. Karastergiou, K et al, “Sex differences in human adipose tissues – the biology of pear shape,” Biol. Sex Differ., vol. 3, no. 1, p. 13, 2012, doi: 10.1186/2042-6410-3-13.
  66. Nauli, A M et al, “Why Do Men Accumulate Abdominal Visceral Fat?” Front. Physiol., vol. 10, p. 1486, Dec. 2019, doi: 10.3389/fphys.2019.01486.
  67. Thorpe Jr., R J et al, “Aging, Obesity, and Mortality: Misplaced Concern About Obese Older People?” Res Aging. 2004 Jan 1; 26(1): 108–129. doi: 10.1177/0164027503258738.
  68. Yanovski, J A “Pediatric obesity. An introduction” Appetite. 2015 Oct 1; 93: 3–12. Published online 2015 Mar 30. doi: 10.1016/j.appet.2015.03.028.
  69. “About Child & Teen BMI – Center for Disease Control and Prevention” Available: https://www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html.
  70. Chung, S “Growth and Puberty in Obese Children and Implications of Body Composition” J Obes Metab Syndr. 2017 Dec; 26(4): 243–250. Published online 2017 Dec 30. doi: 10.7570/jomes.2017.26.4.243.
  71. St-Onge, M P et al, “Body composition changes with aging: The cause or the result of alterations in metabolic rate and macronutrient oxidation?” Nutrition. 2010 Feb; 26(2): 152–155. Published online 2009 Dec 8. doi: 10.1016/j.nut.2009.07.004.
  72. Studenski, S A et al, “The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates,” J. Gerontol. A. Biol. Sci. Med. Sci., vol. 69, no. 5, pp. 547–558, May 2014, doi: 10.1093/gerona/glu010.
  73. McKee, A et al, “Obesity in the Elderly” In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.
  74. Van Der Valk, E S et al, “A comprehensive diagnostic approach to detect underlying causes of obesity in adults” Obesity Reviews First published: 01 March 2019 https://doi.org/10.1111/obr.12836.
  75. Hetherington-Rauth, M et al, “Comparison of direct measures of adiposity with indirect measures for assessing cardiometabolic risk factors in preadolescent girls” Nutr J. 2017; 16: 15. Published online 2017 Feb 23. doi: 10.1186/s12937-017-0236-7.
  76. Janssen, I et al, “Waist circumference and not body mass index explains obesity-related health risk” The American Journal of Clinical Nutrition, Volume 79, Issue 3, March 2004, Pages 379–384, https://doi.org/10.1093/ajcn/79.3.379.
  77. Robert Ross et al, “Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity” Nat Rev Endocrinol. 2020; 16(3): 177–189. Published online 2020 Feb 4. doi: 10.1038/s41574-019-0310-7.
  78. “Why is my waist size important? - NHS.” [Online]. Available: https://www.nhs.uk/common-health-questions/lifestyle/why-is-my-waist-size-important/.
  79. “Metabolic syndrome - Symptoms and causes - Mayo Clinic.” [Online]. Available: https://www.mayoclinic.org/diseases-conditions/metabolic-syndrome/symptoms-causes/syc-20351916.
  80. “Metabolic Syndrome – Cedars Sinai” [Online]. Available: https://www.cedars-sinai.org/health-library/diseases-and-conditions/m/metabolic-syndrome.html.
  81. “Metabolic Syndrome | NHLBI, NIH.” [Online]. Available: https://www.nhlbi.nih.gov/health-topics/metabolic-syndrome.
  82. “HDL cholesterol: How to boost your ‘good’ cholesterol - Mayo Clinic.” [Online]. Available: https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/hdl-cholesterol/art-20046388.
  83. Yanai, H et al, “The underlying mechanisms for development of hypertension in the metabolic syndrome” Nutr J. 2008; 7: 10. Published online 2008 Apr 17. doi: 10.1186/1475-2891-7-10.
  84. “What is Cardiovascular Disease? | American Heart Association.” [Online]. Available: https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease
  85. “Type 2 Diabetes - Symptoms | ADA.” [Online]. Available: https://www.diabetes.org/diabetes/type-2/symptoms.
  86. Arenillas, J F et al, “The Metabolic Syndrome and Stroke - Potential Treatment Approaches” Stroke Originally published 31 May 2007 https://doi.org/10.1161/STROKEAHA.106.480004.
  87. Lin, H et al, “The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article” Medicine (Baltimore). 2017 Nov; 96(47): e8838. Published online 2017 Nov 27. doi: 10.1097/MD.0000000000008838.
  88. Hinnouho, G M et al, “Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?,” Diabetes Care, vol. 36, no. 8, pp. 2294–2300, Aug. 2013, doi: 10.2337/dc12-1654.
  89. Eknoyan, G. “Adolphe Quetelet (1796–1874) — the average man and indices of obesity” Nephrology Dialysis Transplantation, Volume 23, Issue 1, January 2008, Pages 47–51, https://doi.org/10.1093/ndt/gfm517.
  90. Abou Ziki, M D et al, “Metabolic Syndrome: Genetic Insights into Disease Pathogenesis” Curr Opin Lipidol. 2016 Apr; 27(2): 162–171. doi: 10.1097/MOL.0000000000000276.
  91. Kolb, H et al, “Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes.” BMC Med 15, 131 (2017). https://doi.org/10.1186/s12916-017-0901-x.
  92. Jensen, M D “Role of Body Fat Distribution and the Metabolic Complications of Obesity” J Clin Endocrinol Metab. 2008 Nov; 93(11 Suppl 1): S57–S63. doi: 10.1210/jc.2008-1585.
  93. Wildman, R P et al, “The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes Among the US Population (NHANES 1999-2004),” Arch. Intern. Med., vol. 168, no. 15, pp. 1617–1624, Aug. 2008, doi: 10.1001/archinte.168.15.1617.
  94. Bhaskaran, K et al, “Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK” Lancet Diabetes Endocrinol. 2018 Dec; 6(12): 944–953. doi: 10.1016/S2213-8587(18)30288-2.
Je li vam ovaj sadržaj bio koristan?

POVEZANI ČLANCI

Klasifikacija težine 1, 2 ili 3: Koja je razlika?
BMI | 5 min. čitanja

Klasifikacija težine 1, 2 ili 3: Koja je razlika?

Saznajte kako se tjelesna težina klasificira prema ITM-u, što znače klase debljine 1, 2 i 3 te kada debljina postaje opasna po zdravlje. Provjerite kad je vrijeme za stručnu pomoć.

Pronađite više povezanih članaka